ERBB2 and breast carcinoma: To exploit the pro-endocytic potential of developedproteins, we constructed the tetravalent fluorescent cytotoxic conjugateTetraFHER2-vcMMAE and demonstrated its high potency andselectivity against HER2+ breast cancer cells.